Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow's feet

Plastic and Reconstructive Surgery

Volumn 105, Issue 6, 2000, Pages 2219-2225

  Guerrissi, Jorge O ^a,b  

^a HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE CALCULATION; DRUG EFFICACY; EYELID RECONSTRUCTION; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MUSCLE CONTRACTION; ORBICULARIS ORIS MUSCLE; PATIENT SATISFACTION; PRIORITY JOURNAL; RHYTIDOPLASTY; TREATMENT OUTCOME;

EID: 0034012336     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200005000-00049     Document Type: Article

References (17)

1. Scott, A. B. Botulinum toxin injection of eye muscle to correct strabismus. Trans. Am. Ophthalmol. Soc. 79: 734, 1981.
2. Scott, A. B., Rosenbaum, A., and Collins, C. C. Pharmacologic weakening of extraocular muscles. Invest. Ophthalmol 12: 924, 1973.
3. Elston, J. S. Botulinum toxin treatment of blepharospasm. Adv. Neurol. 50: 579, 1988.
4. Clark, R. P., and Berris, C. E. Botulinum toxin: A treatment for facial asymmetry caused by facial nerve paralysis. Plast. Reconstr. Surg. 84: 353, 1989.
5. Koller, W., Vetere-Overfield, B., Cray, C., and Dubinsky, R. Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis. Clin. Neuropharmacol. 13: 355, 1990.
6. Rees, T. D. Blepharoplasty. In Aesthetic Plastic Surgery, Vol. II. Philadelphia: Saunders, 1980. Pp. 463-464.
7. Keen, M., Blitzer, A., Aviv, J., et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plast. Reconstr. Surg. 94: 94, 1994.
8. Guerrissi, J., and Sarkissian, P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann. Plast. Surg. 39: 447, 1997.
9. Fagien, S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast. Reconstr. Surg. 103: 701, 1999.
10. Melling, J., Hambleton, P., and Shone, C. C. Clostridium botulinum toxins: Nature and preparation for clinical use. Eye 2: 16, 1988.
11. Schmidt, J. J., Sathyamoorthy, V., and Das Gupta, B. R. Partial amino acid sequence of the heavy and light chains of botulinum neurotoxin type A. Biochem. Biophys. Res. Commun. 119: 900, 1984.
12. Scott, A. B., Kennedy, R. A., and Stubbs, H. A. Botulinum A toxin injection as a treatment for blepharospasm. Arch. Ophthalmol. 103: 347, 1985.
13. Cohen, D. A., Savino, P.J., Stern, M. B., and Hurtig, H. I. Botulinum injection therapy for blepharospasm: A review and report of 75 patients. Clin. Neuropharmacol. 9: 415, 1986.
14. Schantz, E., and Scott, A. Use of Crystalline Type A Botulinum Toxin in Medical Research. In G. E. Leweis (Ed.), Biomedical Aspects of Botulinum. New York: Academic Press, 1981. Pp. 143-149.
15. Osako, M., and Keltner, J. L. Botulinum A toxin (Oculinum) in ophthalmology. Surv. Ophthalmol. 36: 28, 1991.
16. Stanley, E., and Drachman, D. Botulinum toxin blocks quantal but not quantal release of ACH at the neuromuscular junction. Brain Res. 261: 172, 1983.
17. Paff, G. H. Introduction to the Anatomy of the Head. In G. H. Paff (Ed.), Anatomy of the Head and Neck. Philadelphia: Saunders, 1973. Pp. 37-57.